Cells were treated with 10nM, 100nM and 1M BI-847325 (Boehringer Ingelheim), 30nM trametinib (Selleck), 1M VX680 (Selleck) for 48h

Cells were treated with 10nM, 100nM and 1M BI-847325 (Boehringer Ingelheim), 30nM trametinib (Selleck), 1M VX680 (Selleck) for 48h. of individuals receiving the BRAF/MEK inhibitor combination and further restorative strategies…

Continue ReadingCells were treated with 10nM, 100nM and 1M BI-847325 (Boehringer Ingelheim), 30nM trametinib (Selleck), 1M VX680 (Selleck) for 48h